A3242: Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen…

A3242 1R [First Reprint] ASSEMBLY, No. 3242 STATE OF NEW JERSEY 222nd LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION Sponsored by: Assemblyman DAN HUTCHISON District 4 (Atlantic, Camden and Gloucester) Assemblywoman MARGIE DONLON, M.D. District 11 (Monmouth) Assemblywoman  HEATHER SIMMONS District 3 (Cumberland, Gloucester and Salem) Co-Sponsored by: Assemblyman Miller SYNOPSIS Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease. CURRENT VERSION OF TEXT As reported by the Assembly Financial Institutions and Insurance Committee on February 12, 2026, with amendments. An Act concerning health benefits coverage and continuous glucose monitoring systems and supplementing various parts of the statutory law. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1.    a.  A hospital service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1938, c.366 (C.17:48-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the contract. c.     This section shall apply to those hospital service corporation contracts in which the hospital service corporation has reserved the right to change the premium. 2.    a.  A medical service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1940, c.74 (C.17:48A-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the contract. c.     This section shall apply to those medical service corporation contracts in which the medical service corporation has reserved the right to change the premium. 3.    a.  A health service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1985, c.236 (C.17:48E-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the contract. c.     This section shall apply to those health service corporation contracts in which the health service corporation has reserved the right to change the premium. 4.    a.  An individual health insurance policy that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:26-1 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the policy. c.     This section shall apply to those individual health insurance policies in which the insurer has reserved the right to change the premium. 5.    a.  A group health insurance policy that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:27-26 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the policy. c.     This section shall apply to those group health insurance policies in which the insurer has reserved the right to change the premium. 6.    a.  An individual health benefits plan that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.161 (C.17B:27A-2 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the plan. c.     This section shall apply to those health benefits plans in which the carrier has reserved the right to change the premium. 7.    a.  A small employer health benefits plan that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.162 (C.17B:27A-17 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the plan. c.     This section shall apply to those health benefits plans in which the carrier has reserved the right to change the premium. 8.    a.  A health maintenance organization contract for health care services that is delivered, issued, executed, or renewed in this State pursuant to P.L.1973, c.337 (C.26:2J-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the contract. c.     This section shall apply to those contracts for health care services under which the health maintenance organization has reserved the right to change the schedule of charges for enrollee coverage. 9.    a.  The State Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act that provides hospital and medical expense benefits shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the contract. 10.    a.  The School Employees’ Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act that provides hospital and medical expense benefits shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease. b.    The benefits shall be provided to the same extent as for any other medical condition under the contract. 11.  This act shall take effect on the first day of the seventh month next following enactment and shall apply to 1 [all health benefits plans] policies and contracts 1 that are delivered, issued, executed 1 [or] , 1 renewed 1 [in this State] 1 , or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act 1 , except that section 6 of this act shall take effect and apply to policies and contracts that are delivered, issued, executed, or renewed pursuant to P.L.1992, c.161 (C.17B:27A-2 et seq.) on January 1, 2027 1 .